Advertisement
Canada markets open in 2 hours 44 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7310
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    82.84
    +0.03 (+0.04%)
     

  • Bitcoin CAD

    86,838.61
    -3,917.09 (-4.32%)
     

  • CMC Crypto 200

    1,349.16
    -33.42 (-2.42%)
     

  • GOLD FUTURES

    2,337.50
    -0.90 (-0.04%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,512.75
    -151.75 (-0.86%)
     

  • VOLATILITY

    16.16
    +0.19 (+1.19%)
     

  • FTSE

    8,089.56
    +49.18 (+0.61%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6813
    -0.0006 (-0.09%)
     

Today's Research Reports on Hemostemix, Cotinga Pharmaceuticals, Aurinia Pharmaceuticals and Baylin Technologies

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / June 22, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Hemostemix Inc.
https://rdinvesting.com/news/?ticker=HEM.V

Cotinga Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=COT.V

Aurinia Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=AUP.TO

Baylin Technologies Inc.
https://rdinvesting.com/news/?ticker=BYL.TO

Hemostemix's stock had no change Thursday, to close the day at $0.08. The stock recorded a trading volume of 428,800 shares, which was above its three months average volume of 388,728 shares. In the last year, Hemostemix's shares have traded in a range of 0.05 - 0.16. The share price has gained 60.00% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.08 is greater than its 200-day moving average of $0.07. Shares of Hemostemix have gained approximately 14.29 percent year-to-date.

ADVERTISEMENT

Access RDI's Hemostemix Inc. Research Report at:

https://rdinvesting.com/news/?ticker=HEM.V

On Thursday, shares of Cotinga Pharmaceuticals recorded a trading volume of 2,500 shares, which was below the three months average volume of 15,784 shares. The stock ended the day 8.33% lower at 0.55. The share price has gained 89.66% from its 52 week low with a 52 week trading range of 0.29 - 2.60. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.69 is below its 200-day moving average of $0.73. Shares of Cotinga Pharmaceuticals have fallen approximately 50 percent year-to-date.

Access RDI's Cotinga Pharmaceuticals Inc. Research Report at:

https://rdinvesting.com/news/?ticker=COT.V

Aurinia Pharmaceuticals' stock moved 2.73% lower Thursday, to close the day at $7.83. The stock recorded a trading volume of 55,972 shares, which was above its three months average volume of 34,425 shares. In the last year, Aurinia Pharmaceuticals' shares have traded in a range of 5.68 - 9.75. The share price has gained 37.85% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $7.41 is greater than its 200-day moving average of $6.87. Shares of Aurinia Pharmaceuticals have gained approximately 36.89 percent year-to-date.

Access RDI's Aurinia Pharmaceuticals Inc. Research Report at:

https://rdinvesting.com/news/?ticker=AUP.TO

On Thursday, shares of Baylin Technologies recorded a trading volume of 4,950 shares, which was below the three months average volume of 25,876 shares. The stock ended the day 0.88% higher at 3.44. The share price has gained 83.96% from its 52 week low with a 52 week trading range of 1.87 - 4.12. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $3.35 is below its 200-day moving average of $3.47.

Access RDI's Baylin Technologies Inc. Research Report at:

https://rdinvesting.com/news/?ticker=BYL.TO

Our Actionable Research on Hemostemix Inc. (TSXV: HEM.V) and Cotinga Pharmaceuticals Inc. (TSXV: COT.V) and Aurinia Pharmaceuticals Inc. (TSX: AUP.TO) and Baylin Technologies Inc. (TSX: BYL.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address: Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email: contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com